Mirshahidi H - Search Results

1

Successful Treatment of Autoimmune Hemolytic Anemia Concomitant with Proliferation of Epstein-Barr Virus in a Post-Heart Transplant Patient.

Castillo DR, Sheth P, Nishino K, Stevens WT, Nguyen A, Romagnolo A, Mirshahidi H. Castillo DR, et al. Among authors: mirshahidi h. Hematol Rep. 2022 Aug 17;14(3):261-264. doi: 10.3390/hematolrep14030036. Hematol Rep. 2022. PMID: 35997403 Free PMC article.

2

Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics.

Nahleh Z, Otoukesh S, Mirshahidi HR, Nguyen AL, Nagaraj G, Botrus G, Badri N, Diab N, Alvarado A, Sanchez LA, Dwivedi AK. Nahleh Z, et al. Cancer Med. 2018 Jun;7(6):2710-2717. doi: 10.1002/cam4.1509. Epub 2018 May 7. Cancer Med. 2018. PMID: 29733543 Free PMC article.

3

A rare case of extremely delayed osseous metastasis of pineoblastoma.

Nguyen AL, Chong EG, Lee J, Mirshahidi S, Mirshahidi H. Nguyen AL, et al. Among authors: mirshahidi h. Rare Tumors. 2021 Jun 20;13:2036361320975752. doi: 10.1177/2036361320975752. eCollection 2021. Rare Tumors. 2021. PMID: 34221289 Free PMC article.

4

A case report of imiquimod topical therapy as treatment for cutaneous metastasis of breast cancer.

Nguyen AL, Chong EG, Lee J, Mirshahidi S, Mirshahidi H. Nguyen AL, et al. Among authors: mirshahidi h. Rare Tumors. 2021 Jun 24;13:2036361320975748. doi: 10.1177/2036361320975748. eCollection 2021. Rare Tumors. 2021. PMID: 34249290 Free PMC article.

5

Recurrent and atypical immune checkpoint inhibitor-induced pneumonitis.

Jeon WJ, Nguyen J, Castillo DR, Park K, Brothers J, Nguyen A, Mirshahidi H. Jeon WJ, et al. Among authors: mirshahidi h. J Oncol Pharm Pract. 2023 Jul;29(5):1264-1267. doi: 10.1177/10781552221150936. Epub 2023 Jan 17. J Oncol Pharm Pract. 2023. PMID: 36648206

6

Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature.

Shaheen S, Mirshahidi H, Nagaraj G, Hsueh CT. Shaheen S, et al. Among authors: mirshahidi h. Exp Hematol Oncol. 2018 May 8;7:11. doi: 10.1186/s40164-018-0104-y. eCollection 2018. Exp Hematol Oncol. 2018. PMID: 29761026 Free PMC article.

7

Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma.

Pourhassan HZ, Tryon D, Schaeffer B, Mirshahidi H, Wong J. Pourhassan HZ, et al. Among authors: mirshahidi h. Exp Hematol Oncol. 2019 Sep 10;8:20. doi: 10.1186/s40164-019-0140-2. eCollection 2019. Exp Hematol Oncol. 2019. PMID: 31516766 Free PMC article.

8

Updates in non-small cell lung cancer--insights from the 2009 45th annual meeting of the American Society of Clinical Oncology.

Mirshahidi HR, Hsueh CT. Mirshahidi HR, et al. J Hematol Oncol. 2010 May 2;3:18. doi: 10.1186/1756-8722-3-18. J Hematol Oncol. 2010. PMID: 20433767 Free PMC article. Review.

9

Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP.

Yuan Y, Liao YM, Hsueh CT, Mirshahidi HR. Yuan Y, et al. J Hematol Oncol. 2011 Apr 20;4:16. doi: 10.1186/1756-8722-4-16. J Hematol Oncol. 2011. PMID: 21504625 Free PMC article. Review.

10

A novel insertion mutation on exon 20 of epidermal growth factor receptor, conferring resistance to erlotinib.

Khan NA, Mirshahidi S, Mirshahidi HR. Khan NA, et al. Case Rep Oncol. 2014 Jul 16;7(2):491-6. doi: 10.1159/000365325. eCollection 2014 May. Case Rep Oncol. 2014. PMID: 25202264 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page